Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 5 of 5 entries
Sorted by: Best Match Show Resources per page
Long-Term Effectiveness, Safety, and Tolerability of Twice-Daily Dosing with Deferasirox in Children with Transfusion-Dependent Thalassemias Unresponsive to Standard Once-Daily Dosing.

Mediterranean journal of hematology and infectious diseases

Buaboonnam J, Takpradit C, Viprakasit V, Narkbunnam N, Vathana N, Phuakpet K, Sanpakit K, Pongtanakul B.
PMID: 34804439
Mediterr J Hematol Infect Dis. 2021 Nov 01;13(1):e2021065. doi: 10.4084/MJHID.2021.065. eCollection 2021.

BACKGROUND: Patients with transfusion-dependent thalassemia PATIENTS AND METHODS: We retrospectively studied the serum-ferritin (SF), and liver-iron-concentration (LIC) outcomes of patients with TDT treated with twice-daily dosing of deferasirox (TDD-DFX) > 24 months, after failing to respond to once-daily deferasirox...

Cite
Buaboonnam J, Takpradit C, Viprakasit V, et al. Long-Term Effectiveness, Safety, and Tolerability of Twice-Daily Dosing with Deferasirox in Children with Transfusion-Dependent Thalassemias Unresponsive to Standard Once-Daily Dosing. Mediterr J Hematol Infect Dis. 2021;13(1):e2021065doi: 10.4084/MJHID.2021.065.
Buaboonnam, J., Takpradit, C., Viprakasit, V., Narkbunnam, N., Vathana, N., Phuakpet, K., Sanpakit, K., & Pongtanakul, B. (2021). Long-Term Effectiveness, Safety, and Tolerability of Twice-Daily Dosing with Deferasirox in Children with Transfusion-Dependent Thalassemias Unresponsive to Standard Once-Daily Dosing. Mediterranean journal of hematology and infectious diseases, 13(1), e2021065. https://doi.org/10.4084/MJHID.2021.065
Buaboonnam, Jassada, et al. "Long-Term Effectiveness, Safety, and Tolerability of Twice-Daily Dosing with Deferasirox in Children with Transfusion-Dependent Thalassemias Unresponsive to Standard Once-Daily Dosing." Mediterranean journal of hematology and infectious diseases vol. 13,1 (2021): e2021065. doi: https://doi.org/10.4084/MJHID.2021.065
Buaboonnam J, Takpradit C, Viprakasit V, Narkbunnam N, Vathana N, Phuakpet K, Sanpakit K, Pongtanakul B. Long-Term Effectiveness, Safety, and Tolerability of Twice-Daily Dosing with Deferasirox in Children with Transfusion-Dependent Thalassemias Unresponsive to Standard Once-Daily Dosing. Mediterr J Hematol Infect Dis. 2021 Nov 01;13(1):e2021065. doi: 10.4084/MJHID.2021.065. eCollection 2021. PMID: 34804439; PMCID: PMC8577551.
Copy Download .nbib Format: NLM
GD2-specific chimeric antigen receptor-modified T cells targeting retinoblastoma - assessing tumor and T cell interaction.

Translational oncology

Sujjitjoon J, Sayour E, Tsao ST, Uiprasertkul M, Sanpakit K, Buaboonnam J, Yenchitsomanus PT, Atchaneeyasakul LO, Chang LJ.
PMID: 33321428
Transl Oncol. 2021 Feb;14(2):100971. doi: 10.1016/j.tranon.2020.100971. Epub 2020 Dec 13.

A novel disialoganglioside 2 (GD2)-specific chimeric antigen receptor (CAR)-modified T cell therapy against retinoblastoma (RB) were generated. GD2-CAR consists of a single-chain variable fragment (scFv) derived from a monoclonal antibody, hu3F8, that is linked with the cytoplasmic signaling domains...

Cite
Sujjitjoon J, Sayour E, Tsao ST, et al. GD2-specific chimeric antigen receptor-modified T cells targeting retinoblastoma - assessing tumor and T cell interaction. Transl Oncol. 2020;14(2):100971doi: 10.1016/j.tranon.2020.100971.
Sujjitjoon, J., Sayour, E., Tsao, S. T., Uiprasertkul, M., Sanpakit, K., Buaboonnam, J., Yenchitsomanus, P. T., Atchaneeyasakul, L. O., & Chang, L. J. (2021). GD2-specific chimeric antigen receptor-modified T cells targeting retinoblastoma - assessing tumor and T cell interaction. Translational oncology, 14(2), 100971. https://doi.org/10.1016/j.tranon.2020.100971
Sujjitjoon, Jatuporn, et al. "GD2-specific chimeric antigen receptor-modified T cells targeting retinoblastoma - assessing tumor and T cell interaction." Translational oncology vol. 14,2 (2021): 100971. doi: https://doi.org/10.1016/j.tranon.2020.100971
Sujjitjoon J, Sayour E, Tsao ST, Uiprasertkul M, Sanpakit K, Buaboonnam J, Yenchitsomanus PT, Atchaneeyasakul LO, Chang LJ. GD2-specific chimeric antigen receptor-modified T cells targeting retinoblastoma - assessing tumor and T cell interaction. Transl Oncol. 2021 Feb;14(2):100971. doi: 10.1016/j.tranon.2020.100971. Epub 2020 Dec 13. PMID: 33321428; PMCID: PMC7745061.
Copy Download .nbib Format: NLM
A Comparison of the Clinical Outcomes of Haploidentical Transplantation and Other Graft Sources in Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis.

Clinical lymphoma, myeloma & leukemia

Owattanapanich W, Leelakanok N, Sanpakit K, Buaboonnam J.
PMID: 34802994
Clin Lymphoma Myeloma Leuk. 2021 Oct 20; doi: 10.1016/j.clml.2021.09.024. Epub 2021 Oct 20.

BACKGROUND: Most likely due to the availability of potential stem cell sources, there appears to be a growing usage of haploidentical (haplo) donors for cases of acute lymphoblastic leukemia involving high-risk features or relapse.PATIENTS AND METHODS: This study compared...

Cite
Owattanapanich W, Leelakanok N, Sanpakit K, et al. A Comparison of the Clinical Outcomes of Haploidentical Transplantation and Other Graft Sources in Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis. Clin Lymphoma Myeloma Leuk. 2021;doi: 10.1016/j.clml.2021.09.024.
Owattanapanich, W., Leelakanok, N., Sanpakit, K., & Buaboonnam, J. (2021). A Comparison of the Clinical Outcomes of Haploidentical Transplantation and Other Graft Sources in Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis. Clinical lymphoma, myeloma & leukemia, . https://doi.org/10.1016/j.clml.2021.09.024
Owattanapanich, Weerapat, et al. "A Comparison of the Clinical Outcomes of Haploidentical Transplantation and Other Graft Sources in Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis." Clinical lymphoma, myeloma & leukemia vol. (2021). doi: https://doi.org/10.1016/j.clml.2021.09.024
Owattanapanich W, Leelakanok N, Sanpakit K, Buaboonnam J. A Comparison of the Clinical Outcomes of Haploidentical Transplantation and Other Graft Sources in Acute Lymphoblastic Leukemia: A Systematic Review and Meta-Analysis. Clin Lymphoma Myeloma Leuk. 2021 Oct 20; doi: 10.1016/j.clml.2021.09.024. Epub 2021 Oct 20. PMID: 34802994.
Copy Download .nbib Format: NLM
Antifungal Prophylaxis with Posaconazole versus Fluconazole in Children with Neutropenia Following Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience.

Journal of blood medicine

Takpradit C, Wangkittikal C, Rungmaitree S, Buaboonnam J, Narkbunnam N, Phuakpet K, Vathana N, Sanpakit K, Pongtanakul B.
PMID: 34354383
J Blood Med. 2021 Jul 30;12:679-689. doi: 10.2147/JBM.S319890. eCollection 2021.

BACKGROUND: Invasive fungal diseases (IFDs) are common and contribute to mortality in patients undergoing hematopoietic stem cell transplantation (HSCT). The relative efficacies of posaconazole (POS) and fluconazole (FLU) as primary antifungal prophylaxes are uncertain.METHODS: A retrospective study was performed...

Cite
Takpradit C, Wangkittikal C, Rungmaitree S, et al. Antifungal Prophylaxis with Posaconazole versus Fluconazole in Children with Neutropenia Following Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience. J Blood Med. 2021;12:679-689doi: 10.2147/JBM.S319890.
Takpradit, C., Wangkittikal, C., Rungmaitree, S., Buaboonnam, J., Narkbunnam, N., Phuakpet, K., Vathana, N., Sanpakit, K., & Pongtanakul, B. (2021). Antifungal Prophylaxis with Posaconazole versus Fluconazole in Children with Neutropenia Following Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience. Journal of blood medicine, 12679-689. https://doi.org/10.2147/JBM.S319890
Takpradit, Chayamon, et al. "Antifungal Prophylaxis with Posaconazole versus Fluconazole in Children with Neutropenia Following Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience." Journal of blood medicine vol. 12 (2021): 679-689. doi: https://doi.org/10.2147/JBM.S319890
Takpradit C, Wangkittikal C, Rungmaitree S, Buaboonnam J, Narkbunnam N, Phuakpet K, Vathana N, Sanpakit K, Pongtanakul B. Antifungal Prophylaxis with Posaconazole versus Fluconazole in Children with Neutropenia Following Allogeneic Hematopoietic Stem Cell Transplantation: Single Center Experience. J Blood Med. 2021 Jul 30;12:679-689. doi: 10.2147/JBM.S319890. eCollection 2021. PMID: 34354383; PMCID: PMC8331121.
Copy Download .nbib Format: NLM
Invasive Fungal Diseases in Children with Acute Leukemia and Severe Aplastic Anemia.

Mediterranean journal of hematology and infectious diseases

Supatharawanich S, Narkbunnam N, Vathana N, Takpradit C, Phuakpet K, Pongtanakul B, Tongsai S, Sinlapamongkolkul P, Ngamskulrungroj P, Phongsamart W, Sanpakit K, Buaboonnam J.
PMID: 34276908
Mediterr J Hematol Infect Dis. 2021 Jul 01;13(1):e2021039. doi: 10.4084/MJHID.2021.039. eCollection 2021.

Although the outcomes of childhood leukemia and severe aplastic anemia (SAA) have improved, infectious complications are still the major concern. Particularly worrisome are invasive fungal diseases (IFDs), one of the most common causes of infectious-related deaths in patients with...

Cite
Supatharawanich S, Narkbunnam N, Vathana N, et al. Invasive Fungal Diseases in Children with Acute Leukemia and Severe Aplastic Anemia. Mediterr J Hematol Infect Dis. 2021;13(1):e2021039doi: 10.4084/MJHID.2021.039.
Supatharawanich, S., Narkbunnam, N., Vathana, N., Takpradit, C., Phuakpet, K., Pongtanakul, B., Tongsai, S., Sinlapamongkolkul, P., Ngamskulrungroj, P., Phongsamart, W., Sanpakit, K., & Buaboonnam, J. (2021). Invasive Fungal Diseases in Children with Acute Leukemia and Severe Aplastic Anemia. Mediterranean journal of hematology and infectious diseases, 13(1), e2021039. https://doi.org/10.4084/MJHID.2021.039
Supatharawanich, Sutatta, et al. "Invasive Fungal Diseases in Children with Acute Leukemia and Severe Aplastic Anemia." Mediterranean journal of hematology and infectious diseases vol. 13,1 (2021): e2021039. doi: https://doi.org/10.4084/MJHID.2021.039
Supatharawanich S, Narkbunnam N, Vathana N, Takpradit C, Phuakpet K, Pongtanakul B, Tongsai S, Sinlapamongkolkul P, Ngamskulrungroj P, Phongsamart W, Sanpakit K, Buaboonnam J. Invasive Fungal Diseases in Children with Acute Leukemia and Severe Aplastic Anemia. Mediterr J Hematol Infect Dis. 2021 Jul 01;13(1):e2021039. doi: 10.4084/MJHID.2021.039. eCollection 2021. PMID: 34276908; PMCID: PMC8265365.
Copy Download .nbib Format: NLM
Showing 1 to 5 of 5 entries